Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

BDH Industries

Market Cap: ₹2.6b

Engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India and Internationally.

Cipla

Market Cap: ₹1.2t

Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

Evoq Remedies

Market Cap: ₹114.0m

Engages in the pharmaceutical business in India.

GlaxoSmithKline Pakistan

Market Cap: PK₨143.2b

Operates as a biopharma company in Pakistan.

Soho Global Health

Market Cap: Rp9.3t

Together with its subsidiaires, operates as a healthcare company in Indonesia.

Abbott India

Market Cap: ₹642.0b

Operates as a pharmaceutical company in India.

Krka d. d

Market Cap: €6.7b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

Genesis IBRC India

Market Cap: ₹844.9m

Does not have significant operations.

Elicera Therapeutics

Market Cap: SEK 233.0m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

EyePoint Pharmaceuticals

Market Cap: US$970.5m

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

Azitra

Market Cap: US$2.6m

An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.

Rapport Therapeutics

Market Cap: US$1.2b

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

MediWound

Market Cap: US$196.0m

A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.

Karolinska Development

Market Cap: SEK 242.8m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

Talphera

Market Cap: US$42.1m

A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.

Aelis Farma

Market Cap: €14.9m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.

Entera Bio

Market Cap: US$82.2m

A clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs.

Cronos Group

Market Cap: CA$1.4b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

BioStem Technologies

Market Cap: US$85.1m

A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.

Climb Bio

Market Cap: US$148.4m

A clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases.

Sionna Therapeutics

Market Cap: US$1.2b

A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

Theravance Biopharma

Market Cap: US$707.6m

A biopharmaceutical company, develops and commercializes of medicines in the United States.

Atea Pharmaceuticals

Market Cap: US$230.1m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.

Innovotech

Market Cap: CA$9.5m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

IXICO

Market Cap: UK£13.0m

Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.

Kiora Pharmaceuticals

Market Cap: US$9.0m

A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.

Purple Biotech

Market Cap: ₪15.9m

A clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.

Longeveron

Market Cap: US$16.8m

A clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.

Medicenna Therapeutics

Market Cap: CA$80.1m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

Quality Chemical Industries

Market Cap: USh430.9b

Manufactures and sells pharmaceutical drugs in Uganda.

Dynavax Technologies

Market Cap: US$1.2b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

CareDx

Market Cap: US$801.6m

Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.

Animalcare Group

Market Cap: UK£171.8m

Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.

IDEAYA Biosciences

Market Cap: US$2.2b

A precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.

HOOKIPA Pharma

Market Cap: US$11.5m

A clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform.

Kiniksa Pharmaceuticals International

Market Cap: US$2.7b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.